×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Part 3: Submission of the NDA – FDA Review and Actions
Session Chair(s)
Karen K. Church, PhD
Principal
Coachella Valley Regulatory Group, United States
- Electronic Submissions
- FDA review of applications and actions on applications
- Amendments to an unapproved application
- Reasons applications are not approved
- PDUFA
Have an account?